Cooperation Forum

Drug Development

Strategies –Technologies -Therapies
03 December 2009, Rudolf-Virchow-Centre, Würzburg

Bildquelle: Merck KGaA; MEV

The cooperation forum will be simultaneously translated  German - English and vice versa.

Bayern Innovativ conceives and organises as coordinator of the international Network Life Science the 4th Cooperation Forum "Drug Development" in close cooperation with the Enterprise Europe Network and the University Würzburg.

Already more than 160 participants from Germany, France, Belgium, Italy and the US are registered, from companies and research organisations such as Aeterna Zentaris,  Amgen, Amptec, AURIGON Life Science, Biomet, Boehringer Ingelheim, Cardiac Research, Daiichi Sankyo, Ditabis, Focus Clinical Drug Development, Fluoron, Fraunhofer-Gesellschaft, GE Healthcare, Genelux, Intana Bioscience, Invitrogen, Morphosys, Oncolead,  PROvendis, Ratiopharm,  Rentschler Biotechnologie, Roche, SGS Lifescience, Thermo Fisher, TransMIT Biotronik, Olympus
Genelux, Wilex, Max-Planck-Innovation as well as the Universities Hamburg, Regensburg, Erlangen and Würzburg.

Main topics:

  • Strategies of drug development in industry and academia
  • Technology platforms for new compounds
  • Translational research
  • Oncology, infectious diseases and immunotherapy

Confirmed speakers, e. g. from Roche, Merck, Novartis, Santaris Pharma, Kinaxo Biotechnologies, TRION Pharma, Dr Margarete Fischer-Bosch Institute Stuttgart, University Würzburg as well as the LMU Munich and the Innovative Medicines Initiative (IMI)

Accompanying events on the preceding day (2 December 2009)

Visit of research groups at the Rudolf-Virchow-Centre, such as structure biology, bio-imaging and drug development for vascular diseases.
Panel discussion and reception
"High-tech location Germany: market chances of innovative drug candidates"



The Cooperation Forum is supported by: